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The membrane attack complex (MAC)1 and immune complexes have been localized 
by immunofluorescence within renal (1) and skin lesions (2) of patients with systemic 
lupus erythematosus (SLE). Concordance between the MAC  and immune complex 
deposition was observed in affected glomeruli, one-third of tubulointerstitial lesions, 
and in all active cutaneous lesions studied. The MAC was restricted to areas of tissue 
injury but was not observed in conjunction with C3-containing immune complexes 
found at the dermal-epidermal junction of normal skin obtained from patients with 
SLE. These observations raise several questions:  (a) Are immune complexes and/or 
nonimmune factors responsible for the generation of the MAC found in areas of tissue 
injury? (b) Does the MAC disrupt the integrity of membranes by mechanisms similar 
to those observed for in vitro lysis of erythrocytes (3), tumor cells  (4), and bacteria 
(5)?  (c)Do  basement  membranes,  cell  membranes,  and  other  structures  such  as 
collagen serve as substrates  for insertion of the MAC?  (d) What  factors inhibit  the 
generation  of MAC  by  putative  complement  fixing  immune  complexes  such  as 
junctional deposits found in normal skin of patients with SLE? 
In order to gain  insight  into  these questions, an experimental immune complex 
glomerulonephritis induced by bovine serum albumin  (BSA)  immunization of rats 
was  studied  (6,  7). The immunopathologic changes occuring in renal tissues mani- 
festing proliferative glomerulonephritis  were  examined  by light,  fluorescence, and 
electron microscopy. The distribution of the MAC, C3, and immune complexes within 
glomerular and tubulointerstitial lesions was assessed in order to evaluate the role of 
the MAC as a mediator of immune-complex-initiated tissue injury. 
Materials and Methods 
Experimental Protocol.  Female Lew rats weighing ~ 125 g (Microbiological  Associates, Wilk- 
ensville, MD) were immunized according to a previously published protocol (7). 3 mg of BSA 
* Supported by U. S. Public Health Service grants AM 21715, A110334, AM28488, AM25254, AM26394 
and AM00847. 
* To whom  reprint  requests should  be  addressed  at  Hahnemann  University, 230  N.  Broad  Street, 
Philadelphia, PA 19102. 
1 Abbreviations used in  this paper:  BC,  Bowman's capsule;  BSA,  bovine serum  albumin;  CL, capillary 
lumen; E, endothelium; FLR, fluorescein-labeled  rabbit; GBM, glomerular basement membrane; HRPO, 
horseradish peroxidase; I, interstitium; i.v., intravenous; M, mesangium; MAC:, membrane attack complex; 
P,  podocyte;  PAP,  peroxidase  anti-peroxidase;  PBS,  phosphate-buffered  saline;  SLE,  systemic  lupus 
erythematosus; TBM, tubular basement membrane; TC, tubular cell; US, urinary space. 
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FIe.  1.  Glutaraldehyde-fixed unlysed  rabbit  erythrocytes,  incubated  with  fresh  rat  or  human 
serum. Cells coated with rat complement components: (A) stained with fluorescein-labeled rabbit 
(FLR) anti-rat  C3;  (B)stained with  FLR  anti-human neoantigen(s); cells  coated  with  human 
complement components;  (C) stained with FLR anti-human neoantigen(s) (× 600).  The erythro- 
cytes stain most intensely for C3 due to the greater amount of C3 deposited during complement 
activation. Cells incubated with rat and human serum containing ethylene diamine tetra-acetic 
acid to inhibit complement activation showed no staining. 
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Fro.  2.  Diagram of temporal relationship between daily i.v. BSA administration and 24-h urinary 
protein excretion. Serum anti-BSA antibody titers were initially 1:4. The asterisks denote the time 
at which precipitating antibody was no longer detectable. The onset of proteinuria coincided with 
the disappearance of precipitating antibodies. 
(Miles Laboratories,  Kankakee,  IL)  emulsified in incomplete Freund's adjuvant was  injected 
subcutaneously on days 0 and  14.  2 wk hence (day 28) the animals received intravenous (i.v.) 
injections--maximal dose 2 mg of BSA daily. At the start of i.v. injections an anti-BSA titer of 
1:4  was  detected  in  all  sera  by  agar  gel  immunodiffusion  tests.  24-h  urinary  protein  was 
measured on samples collected from rats placed in metabolism cages (8). The rats were killed 
73 d  after the start of i.v. injections. Three nonimmunized female Lew rats weighing -125  g 
served as controls. 
Preparation of Antigens.  Rabbit  and rat  proteins were  prepared  by the  following methods: KOFFLER  ET  AL. 
TABLE  I 
Iramunofluorescence Localization of Rat lgG, Rat Complement Proteins, and BSA 
1887 
Tissue localization* of:  Glomeruli*  Peritubular basement 
membrane region 
IgG  ++ to +++l  0 
C3  ++  +  to ++! 
BSA antigen  ++ to +++  0 
BSA antibody  +  0 
MAC  ~  ++  + 
* Results  tabulated  for  six  rats  with  moderate  to  severe  glomerulonephritis  and  three 
nonimmunized control rats. 
* Glomeruli of nonimmunized control rats Were negative for all antigens. 
§ 0, neg; +, ++, and +++, weak, moderate, and strong fluorescence staining. 
! Isolated groups of tubules of non-immunized control rats showed peritubular staining. 
No significant difference was observed for the distribution and staining intensity for C9 and 
neoantigen(s)--markers for the MAC. 
FIo.  3.  Kidney (rat #4516) stained with: (A) FLR anti-rat IgG, diffuse finely and coarsely granular 
deposits  along capillary walls (X 250); (B) FLR anti-rat C3, diffuse deposits similar to IgG (× 250); 
(C) FLR  anti-human  neoantigen(s),  diffuse  granular  deposits,  bright  fluorescence  with  a  more 
restricted distribution along glomerular capillary walls (× 250). 
FIc.  4.  Kidney (rat #4530) stained with: (,4) FLR anti-BSA, granular deposits  diffusely scattered 
throughout glomerulus outlining capillary walls (× 250);  (B) Fluorescein-labeled BSA, few weakly 
staining deposits  detectable along glomerular capillary walls (× 250). 
rabbit  and  rat  IgG (9);  rat C3  (10);  and  rat C9  (11).  Sodium dodecyl sulfate polyacrylamide 
gel  electrophoresis  of these  proteins  showed  characteristic  banding  patterns.  The  functional 
integrity of rat C3 and (39 was assessed. Hemolytic activity of (33 was assayed using activated 
sheep  erythrocytes  bearing  human  complement  components  C1,  C4,  and  C2,  which  were 
incubated  with aliquots of rat  C3 and  guinea pig serum depleted of C3 to which rat C3 was 1888  MEMBRANE ATTACK COMPLEX  IN  EXPERIMENTAL  NEPHRITIS 
Fro.  5.  Kidney (rat #-4663), unfixed cryostat sections before and after incubation with acid buffer: 
(A) FLR anti-rat IgG, glomerulus shows a few residual faintly fluorescent  granules along capillary 
walls (x 250). (B) FLR anti-rat C9, granular deposits of rat C9 unaffected by acid buffer treatment 
for  2  h  (× 250). Note:  FLR  anti-rat  C9  and  FLR  anti-human  neoantigen(s)  showed  parallel 
distribution in tissue sections and both were considered to be markers  for rat MAC. (C) FLR anti- 
rat IgG, granular deposits of IgG prior to elution with acid buffer (× 250). (D) FLR anti-rat C9, 
granular deposits  of MAC prior to elution with acid buffer (× 250). 
Fro.  6.  (A) Kidney (rat ~4663); peritubular interstitial deposits of C3, patchy localization within 
irregularly  thickened  TBM  (× 400).  (B) Nonimmunized  control  rat  kidney;  cluster  of tubules 
showing homogeneous linear fluorescence for rat C3 in peritubular region (× 250). The discontinuous 
pattern observed in A was uncommon in nonimmunized animals. 
added (12). Rat C9 was assayed with erythrocytes coated with the C5b-8 complex (11).  Human 
MAC was isolated and characterized as previously described (13). 
Preparation of Antisera.  Rabbits  were  immunized  with  rat  IgG,  rat  C3,  human  MAC, 
crystalline BSA, and  horseradish  peroxidase  (HRPO)  (Sigma Chemical Co., St.  Louis, MO). 
Goats  were  immunized  with  rabbit  IgG.  The  specificity of each  antiserum  was  determined 
using immunoelectrophoresis except for rabbit  anti-MAC.  Monospecific antiserum  to human 
MAC neoantigen(s) was prepared and characterized as previously described (1,  14). Antiserum 
titers were assayed  by double agar gel immunodiffusion  in  1% agarose.  Purified  antigen  (0.2 KOFFLER  ET  AL.  1889 
Fro.  7.  Kidney  (rat  #4664):  (A) Plastic embedded section  stained with hemotoxylin and eosin 
demonstrating moderate proliferative giomerulonephritis; (B) Cryostat section  stained with rabbit 
anti-rat C3 (PAP method). Granular deposits  of C3 in peripheral capillary loops and mesangium 
show similar distribution and reactivity as that obtained by immunofluorescence (× 200). 
TABLE  II 
Ultrastructural Localization of Immune Complex, C3, and the MAC 
Cell  Lamina 
Glomerular localiza-  mem-  rara in-  Lamina  Lamina rara  Podocyte 
tion of:  branes*  terna*  densa  externa  0  membranes 
BSA  0  +!  +  +  0 
lgG  0  ++  ++  +++  0 
C3  0  ++  ++  +++  + 
C9  0  ++  +  +++  ++ 
N~anti~n~  0  +  0  +++  +++ 
* Endothelial, mesangial, and visceral epithelium (excluding podocyte membranes). 
* Subendothelial region of GBM. 
0 Subepithelial region of GBM. 
I Comparativ  e grading (qualitative) of peroxidase reactivity with respect  to staining intensity and distri- 
bution;  dense deposits  considered +++,  used  as standard;  ++,  moderate staining with more limited 
distribution; +, mild, weak staining reaction with limited distribution; 0, not demonstrable. 
mg/ml) was placed in the center well and antiserum titers were expressed as the highest dilution 
that  produced a  positive precipitin reaction: anti-rat  IgG,  1:16; anti-rabbit  IgG,  1:16; anti-rat 
C3,  1:8; anti-rat  C9,  1:16; anti-BSA,  1:32; anti-HRPO,  1:16; and anti-human  MAC neoanti- 
gen (s),  1:4. 
Each antiserum and BSA antigen was conjugated with 0.02 mg of fluorescein isothiocyanate 
(Becton,  Dickinson  and  Co., Cockeysville, MD)  per mg of protein  (15).  Fluorescein-labeled 
gamma  globulins were  rechromatographed  on  DEAE-cellulose. Antisera  with  the  following 
fluorescein/protein ratios were used  for immunofluorescence staining:  anti-rat  IgG, 2.1;  anti- 
rat, C3, 2.3; anti-rat (29,  2.6; anti-BSA, 3.5; and anti-neoantigen(s),  2.5. 
In order to test the in vitro reactivity and specificity of the above fluorescein-labeled reagents 
glutaraldehyde-fixed  rabbit  erythrocytes  coated  with  complement  were  used.  Fresh  rabbit 
erythrocytes suspended in normal saline containing 0.02 M  phosphate, pH 7.2 (PBS) were fixed 
with 0.05% glutaraldehyde for 1 h  at room temperature. The cells were washed five times with 
veronal-buffered saline containing CaC12 and MgCI~, followed by reaction with either fresh rat 
or human serum for 1 h  at 37°C, then washed and resuspended in PBS. The erythrocytes were 
incubated with fluorescein-labeled antibody for 1 h, washed, and  10-#1 aliquots were placed on 
a  glass slide and  examined. The cross-reactivity of human  MAC with rat  MAC was demon- 1890  MEMBRANE ATTACK COMPLEX  IN  EXPERIMENTAL  NEPHRITIS 
Fla.  8.  Kidney (rat #4665):  (A) Routine electron microscopy of peripheral capillary loop showing 
endothelial fenestrae,  subepithelial (arrowheads)  and mesangial  electron dense deposits.  Prominent 
GBM spikes are present  (arrows) (X 10,600). (B) Electron microscopic  immunohistochemistry, sec- 
tions of nonimmunized normal rat kidney reacted with rabbit anti-rat C3 (PAP method used for 
demonstration of tissue  bound antigens).  Glomerular structures  are negative. The low contrast  is 
due to absence of counterstain  (× 20,000). CL, capillary lumen; M, mesangium; P, podocyte, US, 
urinary space. 
strated  using complement-coated  unlysed  glutaraldehyde-fixed  erythrocytes  (Fig.  1).  Rabbit 
erythrocytes coated with rat and human complement components C3 and C5b-9 were incubated 
with  fluorescein-labeled anti-rat  C3, anti-rat  C9,  and  anti-human  neoantigen(s).  Anti-rat  C3 
and C9 gave bright fluorescence of the rabbit erythrocytes, which was specifically inhibited by KOFFLER ET AL.  1891 
purified antigen. The anti-human neoantigen(s) serum reacted with both rat and human MAC 
bound to rabbit erythrocytes and was inhibited by isolated human MAC. 
Purified Fab' fragments of anti-HRPO were prepared by papain digestion and chromatog- 
raphy on carboxymethyl-cellulose. The peroxidase antiperoxidase  (PAP) method was used as 
previously described (16-20). 
Immunofluorescence Techniques.  Small  blocks of tissue  for immunofluorescence were  quick- 
frozen in isopentane/liquid nitrogen at -178°C. Frozen sections (5 #m) were cut using a Harris 
cryostat  (Harris  Mfg.  Co.,  Inc.,  N.  Billeriea,  MA).  Sections  were  stained  by  the  direct 
immunofluorescence  method  and  examined  by  epi-illumination  using  a  Leitz  Orthoplan 
microscope. Photographs were taken using Ektachrome 400 professional film (Eastman Kodak 
Co., Rochester, NY). Specificity controls included the absence of glomerular staining of kidneys 
from normal rats and selective blocking of positive staining by prior incubation with purified 
antigen.  In addition,  anti-neoantigen(s)  serum was incubated with inactivated  whole serum 
and  with  zymosan-activated  serum  before  staining.  Acid  elution  of cryostat  sections  was 
performed by incubation in pH 2.4, 0.2 M glycine for 0.25, 0.5,  1, and 2 h before staining (21). 
Immunoperoxidase Techniques.  Rats under light ether anesthesia were perfused via the abdom- 
inal aorta with PBS for 1 min, followed by perfusion for 20 min with 4% paraformaldehyde in 
PBS according to previously described methods (17-20). Kidney blocks (4 ×  4 ×  1 mm) were 
postfixed  in 4% paraformaldehyde for 2 h  at  4°C and  washed  in multiple  changes of PBS 
containing 4% sucrose at 4°C overnight. Tissues were quick-frozen in isopentane/liquid nitrogen 
and  8-/~m frozen  sections  were  mounted  on  albumin-coated  slides.  After reduction  of free 
aldehyde groups with sodium borohydride, the sections were incubated with 3% normal goat 
serum for 1 h, primary antibody overnight at 4°C, goat anti-rabbit IgG for 2 h and PAP (Fab') 
for 2 h, with appropriate washes in PBS. Sections were incubated in H202-diaminobenzidine 
solution for  15  min  (18),  washed  in  PBS, reacted with  1% OsO4 for  1 h  and  embedded  in 
plastic.  Ultrathin  sections were cut with an LKB-V Uhramicrotome, mounted on uncoated 
grids, examined with a Zeiss EM 10 without any counterstain and photographed using Dupont 
EM film. 
Evaluation of Histopathology.  Tissue  specimens were evaluated  by light  microscopy for in- 
creased cellularity of glomeruli, frequency of polymorphonuclear leukocytes, thickness of the 
glomerular basement  membrane  (GBM),  and  interstitial  infiltration,  according to a  scheme 
described in detail elsewhere (8). 
Results 
Clinical and Morphologic Findings 
The pattern  of urinary protein excretion of six immunized rats  used in this study 
is shown in Fig. 2. Each animal exhibited a  titer of 1:4 for anti-BSA antibody before 
the onset of IV BSA administration.  In three animals precipitating antibodies to BSA 
were no longer detectable  24 d  after the start  of i.v.  BSA injections.  Those animals 
developed  24-h urinary protein  excretion  ranging from 350  to 600  mg at  66 d  and 
histologically  severe  glomerulonephritis  was  observed.  In  one  rat  precipitin  titers 
became negative  at  day 31;  that  animal  showed  moderate  glomerulonephritis  with 
focal interstitial inflammation when killed on day 73. Precipitin titers became negative 
by day  59  in  two  rats.  Those animals  also exhibited  moderate  glomerulonephritis. 
The  onset  of proteinuria  was  correlated  with  disappearance  from  circulation  of 
antibodies detectable by immunodiffusion tests. Severity of the histological lesion was 
related to the duration of proteinuria.  Conventional light microscopic examination of 
sections stained  with  silver methenamine  revealed irregular  thickening of the GBM 
with fine granular subepithelial deposits. Electron microscopic study of kidney sections 
of three  rats  (No.  4663,  4664,  4665)  showed  extensive  glomerular  alterations  that 
included  proliferative  changes,  thickening  of the  basement  membrane  and  dense 
deposits  primarily  in  the  region  of the  lamina  rara  externa.  The  tubulointerstitial 
region showed focal mononuclear cell  infiltrates  with  groups of tubules  surrounded 1892  MEMBRANE ATTACK COMPLEX  IN  EXPERIMENTAL NEPHRITIS 
Fxo. 9.  Kidney (rat ~4665):  Electron microscopic  immunohistochemistry, sections  stained with 
rabbit anti-rat IgG. (A) Renal giomerulus containing diffuse peripheral and mesangial deposits  of 
IgG.  Dense deposits  are prominent  in  subepithelial location, whereas small deposits  (arrow)  are 
found in subendothelial region.  Endothelial cell and podocyte membranes are negative (× 10,000). 
(B) Detail of IgG localization in a peripheral capillary loop. Dense deposits  of IgG in subepithelial 
region with scattered  small deposits  in subendothelial  location  (arrowheads)  and  fine granules  in 
lamina densa.  Note the absence  of foot process membrane localization of IgG (arrows)  (X 18,000). 
Inset, lower left: Endothelial cell membranes were negative for IgG (× 16,000). (C) Higher magnifi- 
cation view of subepithelial immune complex deposits. IgG staining of the deposit is present whereas 
the contiguous podocyte membrane is negative (arrowheads)  (× 30,000). E, endothelium. KOFFLER ET AL.  1893 
by  mild  to  moderate  irregularly thickened  tubular  basement  membranes  (TBM). 
Dense deposits were not observed in the tubulointerstitium. 
Immunohistochemical Studies 
IMMUNOFLUORESCENCV..  Multiple sections of kidneys of six rats with clinical and 
histological evidence of glomerulonephritis and three nonimmunized control rats were 
examined (Table I). IgG and C3 were distributed in a  uniform pattern in glomeruli 
as  fine to coarse granular  deposits or larger aggregates involving capillary walls of 
animals  with  moderate to severe proliferative glomerulonephritis  (Fig.  3 A  and  B). 
Markers for the MAC  (C9 and neoantigen) were limited to sites of immune complex 
deposition  (Fig.  3 C)  but exhibited a  more restricted distribution  than  IgG, C3,  or 
BSA antigen. Discrete mesangial deposits were scattered within glomeruli and showed 
a less intense staining pattern for IgG, C3, and the MAC. 
BSA antigen was identified in a similar pattern as IgG and C3 utilizing fluorescein- 
labeled anti-BSA antibody (Fig. 4A). In contrast to the strong reactivity observed for 
antigen,  fluorescein-labeled BSA revealed only weak staining reactions for free glo- 
merul'ar-bound  anti-BSA  antibody sites  (Fig.  4 B).  Acid  buffer elution  of unfixed 
cryostat sections resulted in marked diminution of fluorescence staining for IgG (Fig. 
5A), C3, BSA antigen, and BSA antibody. Sequential elution with acid buffer at  15 
min, 30 min,  1 h, and 2 h  did not uncover antibody sites within glomerular capillary 
walls.  However, this  procedure demonstrated  that  immune  complexes were eluted 
after periods of 15-30  min  of incubation with  acid  buffer, whereas  the MAC  was 
essentially unaffected by this treatment (Fig. 5 B). 
C3  localization  was  observed  in  the  peritubular  region  of clusters  of proximal 
convoluted  tubules  (Fig.  6A)  associated  with  faint  staining  for  the  MAC,  both 
occurring in a  patchy distribution. IgG was not detectable in either the peritubular 
or interstitial regions. Interstitial infiltrates were relatively sparse and did not correlate 
with peritubular C3 and MAC. Neither BSA antigen nor antibody were detectable in 
the tubulointerstitial region using specific fluorescein-labeled reagents. 1894  MEMBRANE ATTACK COMPLEX  IN EXPERIMENTAL  NEPHRITIS 
FIG. 10.  Kidney (rat #4665): Electron microscopic immunohistochemistry,  sections stained with 
rabbit anti-rat C3 showing: (A) Reaction with granular and dense deposits throughout the basement 
membrane (× 7,500); (B) Detail of peripheral capillary loop. Large subepithelial, small subendo- 
thelial deposits and fine granular particles are present throughout the GBM. Note the distinct 
granular and linear deposits of C3 on foot process membranes contiguous to the GBM (x 25,000). 
Nonimmunized control  rats  exhibited  isolated  groups  of  tubules  that  showed 
peritubular linear fluorescence for C3 (Fig. 6 B) without demonstrable IgG or MAC. 
Renal glomeruli of these animals were negative for immune complexes, C3, and the KOFFLER  ET  AL.  1895 
Fro.  11.  Kidney (rat ~1~665): Electron microscopic immunohistochemistry, sections  stained with 
rabbit  anti-rat  C9 showing:  (A) Intense reactivity of MAC in several  capillary loops.  Mesangial 
matrix is essentially  negative (× 4,000);  (B) Detail of peripheral capillary loop. Large subepithelial 
deposits,  granular subendothelial and  basement  membrane  deposits  are less prominent than C3 
deposits  (compare with Fig.  lOB). Note the fine granular and linear deposits  of C9 on foot process 
membranes adjacent to the GBM (× 24,600). 
MAC. 
IMMUNOPEROXIDASE  REACTIONS.  Cryostat  sections  from  the  kidneys  of three  ne- 
phritic  rats  were  stained  by  the  PAP  method  and  compared  to  sections  incubated 1896  MEMBRANE  ATTACK  COMPLEX  IN  EXPERIMENTAL  NEPHRITIS 
FIG.  12.  Kidney (rat #4665):  Electron microscopic immunohistochemistry, sections stained with 
rabbit anti-human neoantigen(s). (.4) Intense, selective reaction in subepithelial region (X 8,200). 
(B) Detail  of subepithelial deposits and podocyte membrane foot  processes.  Strong reactivity of 
dense deposits with negative basement membrane regions between deposits. Podocyte membrane of 
visceral epithelial cell overlying deposit  is detached and exhibited strong reactivity. C9  and C3 
showed moderate staining whereas IgG and BSA antigen were absent from podocyte membranes 
(X 3 l,ri00). Fro.  13.  Electron  microscopic  immunohistochemistry,  tubulointerstitial  localization.  (A) 
Nonimmunized control rat  kidney section stained with rabbit anti-rat  C3.  Proximal convoluted 
tubule  shows moderate  homogeneous staining reaction  of basement  membrane.  The  interstices 
between basal infoldings (arrowheads) are negative (× 7,600).  Note that sections B-F are obtained 
from nephritic rat  kidneys.  (B) Section  (rat ~4665)  stained with rabbit anti-rat  IgG.  Interstitial 
collagen fibers (arrowheads) are surrounded by IgG and small aggregates are found close to the TBM 
(arrows). Tubular epithelial cells, basement membrane and adjacent Bowman's capsule are negative 
for IgG (x 12,500).  (C) Section (rat #-4665)  stained with rabbit anti-rat IgG. Interstitial collagen 
fibers showed surface IgG. In addition, small aggregates of IgG are present in the interstitial region 
(× 17,300).  (D) Section (rat #4665)  stained with rabbit anti-rat C3. TBM of proximal convoluted 
tubule shows segment of intense homogeneous C3 deposit. Note the difference between intensely 
positive (left) and weakly reactive (right) areas of the TBM (arrows). Interstitial collagen fibers show 
scattered  C3  deposits.  The  inner  luminal  surface  of microvilli  contains  C3  deposits  (x 3,900). 
(E) Section (rat #~4665) stained with rabbit anti-rat C9. TBM shows segmental deposit of C9 which 
has a more granular pattern (compare with D) (× 5,600).  The cell interstices contain C9 (arrowhead). 
(F) Section (rat #-4665)  stained with rabbit anti-human neoantigen(s). TBM  shows discrete seg- 
mental staining which is less intense than that observed with C3 or C9 (D and E)  (× 4,300). The 
cell interstices contain neoantigen (arrowheads). BC, Bowman's capsule; 1, interstitium; TC, tubular 
cell. 
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TABLE III 
Ultrastructural Localization of Tubulointerstitial Protein 
TBM  Interstitial* 
Nephritic (3)  Normal  (3)  Nephritic (3) 
IgG  0*  0  ++§ 
C3  +++  ++  +§ 
C9  ++  +  0 
Neoantigen(s)  +  +  0 
BSA antigen  0  0  0 
* No  proteins were identified in  the  interstitial region of nonimmunized control 
animals. 
O, negative; +, ++, and +++, weak, moderate, and strong peroxidase reactivity. 
§  Not demonstrated by immunofluorescence. 
with fluorescein-labeled reagents. Both techniques detected a  similar distribution  of 
immune complexes, C3, and the MAC in renal lesions, and manifested a comparable 
degree of sensitivity (Fig.  7 B). 
IMMUNOELECTRON MICROSCOPY.  IgG, C3,  BSA  antigen,  and  MAC  markers were 
localized in glomerular structures in three nephritic animals utilizing the PAP method 
(Table  II). Concordant  localization  of IgG, C3,  BSA  antigen,  and  the  MAC  were 
observed within  fine granular deposits located on the subendothelial  surface of the 
lamina rara interna, distributed in a  patchy fashion within the lamina densa and as 
prominent  subepithelial  dense  deposits  present  in  the  region  of the  lamina  rara 
externa  (Figs.  8-12).  In contrast  to IgG and C3,  C9  and particularly neoantigen(s) 
exhibited  a  more  restricted  distribution  with  intense  peroxidase reaction  products 
observed primarily in subepithelial dense deposits (Figs.  11 and  12). The membranes 
of visceral  epithelial  cells  overlying  these  deposits  showed  foot  process  fusion  and 
retraction associated with a distinct granular and irregular linear staining pattern for 
C3  and  the MAC  (Figs.  10-12).  IgG was not observed along podocyte membranes 
(Fig. 9), the only glomerular site manifesting a uniform discordance between IgG and 
complement component  deposits.  Immune complexes, C3,  and  the  MAC  were not 
demonstrable on membranes of endothelial  cells, mesangial cells, or visceral epithe- 
lium located distal from the GBM (Figs. 9-12). Within the mesangial matrix decreased 
staining reactions for both immune complexes and the MAC were observed, compared 
with glomerular capillary walls. Scattered amorphous deposits of immune complexes 
and MAC were also found in Bowman's capsule (Figs. 10A and 11 A). Nonimmunized 
control  rats  did  not  demonstrate  glomerular staining  for any antigens  localized  in 
animals with proliferative glomerulonephritis (Fig. 8 B). 
Proximal convoluted TBM of nephritic animals showed focal deposits of C3 with 
significantly less granular MAC present within the TBM (Fig.  13 and Table III). The 
immunoperoxidase reaction for C3 was visualized as segmental bands of homogeneous 
staining.  IgG  and  C3  were  found  on  the  surface  of collagen  fibers  and  in  small 
aggregates within the interstitium  close to the TBM (Fig.  13 B and C), but IgG was 
not demonstrable within the TBM (Fig.  13 B). 
Nonimmunized control rats exhibited homogeneous linear peritubular C3 deposits 
(Fig.  13A)  in  fewer tubules,  i.e., <10%  as compared with 30%  to 50% of tubules  in KOFFLER ET  AL.  1899 
nephritic animals. Small focal deposits of the MAC were observed within the TBM 
(Figs.  13E and F) but IgG was absent from both the interstitium and the TBM. 
Discussion 
Diffuse glomerular deposits of immune complexes and the MAC were observed in 
the  kidneys of rats  with  proliferative glomerulonephritis  induced by chronic BSA 
administration.  Concordant deposits of IgG, C3, BSA antigen, and the MAC were 
visualized by immunofluorescence predominantly along glomerular capillary walls, 
whereas  the  anti-BSA  antibody  component  of immune  complex  deposits  showed 
minimal reactivity with fluorescein-labeled BSA. Ultrastructural  localization of im- 
mune complexes, C3, and the MAC by immunohistochemical techniques permitted 
a  more precise delineation of the anatomic distribution of these proteins. Prominent 
dense deposits confined primarily to the subepithelial aspect of the GBM contained 
IgG, BSA antigen, C3, and MAC markers. The visceral epithelial cells showed fusion 
and retraction of foot processes in areas overlying dense deposits. Limited reactivity 
for C3  and  intense  staining  for the  MAC  were observed along  segments  of fused 
podocyte membrane although membrane-associated IgG was not demonstrated. IgG, 
C3,  and  the  MAC  were  also  detected  in  the  region  of the  lamina  rara  interna, 
scattered within granular deposits in the lamina densa and in the mesangial matrix. 
Neoantigen(s)  exhibited a  more restricted immunoperoxidase staining pattern than 
that observed for C9, which may be related to the occurrence of fewer neoantigenic 
epitopes on the MAC or to the presence of tissue-bound C9 that was not a component 
of the terminal complement complex. IgG, BSA, C3,  and  MAC  markers were not 
identified  along  cell  membranes  of endothelial  cells,  mesangial  cells,  or  the  non- 
GBM-associated membranes of visceral epithelium. 
These observations suggest that the MAC is generated locally by immune complex 
activation  of  the  classical  complement  pathway,  but  the  MAC  is  restricted  to 
membrane sites that serve as a substrate for insertion, i.e., where immune deposits are 
embedded or partially covered by basement membrane or contiguous to cell mem- 
branes. Previous studies indicate that the MAC may diffuse and insert into membranes 
at sites distant from the activation of the classical complement pathway (22) indicating 
that  MAC  may  bind  independently  of C3  to  cell  membranes.  The  foot  process 
membrane of visceral epithelium is the only site within the glomerulus at which C3b 
receptors have been demonstrated (23-28), although immune complexes and C3 were 
observed throughout the basement membrane of immunized rats. The predominant 
localization  of the  MAC  in  the  region  of the  lamina  rara  externa  suggests  that 
immune complexes migrate through a  damaged GBM and accumulate in the sub- 
epithelial region with consequent activation of the classical complement pathway and 
deposition of C3 and the MAC on podocyte membranes. The failure to demonstrate 
IgG, C3, BSA, or the MAC on endothelial and other cell membranes is most likely 
related to the absence of Fc ~tnd C3b receptors on these membranes except for unique 
circumstances such as induction of receptors by viral infection (29). 
Mechanisms  responsible for the occurrence of proteinuria both in immune-com- 
plex-induced and other forms of glomerulonephritis have been the source of consid- 
erable speculation. The GBM and visceral epithelium are major components of the 
glomerular filtration barrier  (30-32).  Morphologic evidence of injury to the GBM 
and podocyte membrane associated with deposits of the MAC, a  known membran- 1900  MEMBRANE  ATTACK COMPLEX IN EXPERIMENTAL NEPHRITIS 
olytic agent,  suggests  that  this  complement complex is  a  mediator of proteinuria. 
Patients with  nonimmune renal disease resulting from the administration  of puro- 
mycin  (33-37)  and  adriamycin  (38)  manifest  massive  proteinuria  and  nephrotic 
syndrome. These drugs primarily affect cell metabolism but are associated with both 
cell  and  basement  membrane  injury,  which  may  be  mediated  by  the  MAC  or 
analogous agents. Although fusion of foot processes may occur secondary to diffusion 
of excess albumin through the basement membrane (39, 40), it appears that significant 
proteinuria occurs only when injury to both the GBM and podocyte membranes is 
manifest. The predominant localization of immune complexes and the MAC in the 
subepithelial  GBM-podocyte  membrane  region  is  consistent  with  this  thesis.  In 
experimental immune complex and human glomerulonephritis abnormalities of the 
GBM, fusion of visceral epithelial foot processes (41) and "loss" of C3b receptors from 
foot process membranes of human kidney have been demonstrated (42-46). Based on 
observations derived from this study, the loss of the putative C3b receptor, but not of 
intact C3b containing immune complexes is related to binding of C3. The failure to 
demonstrate C3b receptors may also result from injury to the podocyte membrane 
with subsequent functional loss of these receptors. 
The  presence  of glomerular-bound  immune  complexes  containing  excess  BSA 
antigen is characteristic for this experimental model of rat glomerulonephritis. Lew 
rats  manifest  moderate to severe proliferative glomerulonephritis  following two or 
more months of daily i.v. BSA administration (6-8). Deposition of circulating immune 
complexes in antigen excess and/or the addition of BSA antigen to in situ antigen- 
antibody deposits may perpetuate complement activation and thereby enhance both 
the severity and progression of glomerulonephritis. The ability of acid buffer to elute 
immune complexes and C3 from glomeruli of each animal studied suggests that the 
nephritis has not reached the advanced stage found in SLE, where dissociating agents 
may only partially  release  glomerular-bound  complexes from  kidneys  manifesting 
severe nephritis  (1).  The ease with which  immune  complexes are  eluted  from the 
GBM may reflect potential reversibility of a  particular glomerular lesion, although 
further experiments are required to substantiate this hypothesis. In contrast to immune 
complexes, the MAC  is not  significantly affected by acid buffer treatment  in both 
experimental  immune  complex glomerulonephritis  and  human  SLE renal  disease, 
suggesting that  the MAC  is firmly embedded in basement and cell membranes.  In 
vitro experiments have demonstrated that  the MAC  is resistant  to proteolysis and 
dissociation from cell membranes  (47-48). Therefore, the evaluation of serial renal 
biopsies that manifest decreasing amounts of immune complex reactants or a  diag- 
nostic biopsy that  fails to disclose IgG or C3  may reflect more rapid catabolism or 
solubilization of glomerular-bound immune complexes. Further studies are warranted 
to  determine  the  following:  the  stability of the  MAC  as  a  marker  of immune  or 
nonimmune induced tissue injury; the correlation of MAC deposition compared to 
immune complex localization for monitoring progression of glomerulonephritis; and 
the possibility of uncovering immune renal disease for which neither IgG nor C3 have 
been demonstrated (49). 
Tubulointerstitial lesions have not been found to be consistently associated with 
animal  models  of experimental  immune  complex glomerulonephritis  (50-52).  Im- 
munization schedules utilizing antigens such as BSA, which result in the formation of 
circulating immune complexes in antigen excess persisting for long periods of time, KOFFLER  ET  AL.  1901 
have been most closely correlated with the occurrence of tubulointerstitial  disease. 
Previous studies indicate that immune complexes diffuse into the renal parenchyma 
from peritubular capillaries rather than reabsorption from tubular fluids. Kidneys of 
five of six  rats  with  moderate  to  severe  glomerulonephritis  manifested  interstitial 
infiltrates and irregular peritubular C3 and scant MAC deposits in clusters of tubules, 
but IgG was not demonstrable in the tubulointerstitial region utilizing fluorescein- 
labeled reagents.  Immunoelectron microscopy studies, however, indicated that  IgG 
and  C3  were detectable on  the surface of interstitial  collagen fibers contiguous to 
thickened TBM. Segments of the TBM showed homogeneous C3 deposits and smaller 
foci of the MAC, but IgG was not demonstrable within the TBM. These data are 
consistent  with  immune  complex  diffusion  from  peritubular  capillaries,  although 
tubular reabsorption of complexes cannot be excluded. Following activation of the 
classical  complement  pathway  C3  and  the  MAC  are  deposited  within  the  TBM 
thereby serving as a  potential mediator of injury of the TBM. Several observations 
suggest  that  nonimmune  agents,  such  as  bacteria,  may  activate  the  alternative 
complement pathway and contribute to the occurrence of tubulointerstitial lesions: 
(a) the absence ofextraglomerular BSA antigen or antibody in the kidneys of nephritic 
animals;  and  (b) the occurrence of scattered foci of peritubular C3  associated with 
scant deposits of the MAC without interstitial IgG or C3 in control animals. 
The  strong  cross-reactivity between  rat  and  human  neoantigen(s)  suggests  that 
MAC determinants are phylogenetically conserved, a property of proteins and poly- 
peptides  of biological  importance.  The consistent  association of tissue  injury with 
MAC localization in both experimental and human glomerulonephritis supports the 
hypothesis that  the MAC  is an in vivo mediator of membrane toxicity. Numerous 
cell- and serum-derived mediators, such as proteolytic enzymes, kinins, coagulation 
factors, lymphokines, and toxic oxygen metabolites (53-56) have been demonstrated 
within inflammatory reactions. Examination of both physiologic and anatomic pa- 
rameters will  be required  to establish  the  in  vivo pathogenetic significance of the 
MAC, other mediators, and their interaction which may either augment or inhibit 
tissue injury. 
Summary 
The role of the membrane attack complex (MAC)  as a  mediator of renal  tissue 
injury  was  evaluated  in  rats  affected  by  bovine  serum  albumin  (BSA)-induced 
immune complex glomerulonephritis.  Immunofluorescence studies revealed concur- 
rent  deposits  of IgG,  BSA,  C3,  and  the  MAC  along  glomerular  capillary  walls, 
although the MAC manifested a  more restricted distribution than that observed for 
immune complexes. Immunoelectron microscopic techniques were utilized to dem- 
onstrate immune complexes, C3, and the MAC within dense deposits in the subepi- 
thelial aspect of the basement membrane. Visceral epithelial foot processes were fused 
in areas overlying large dense deposits and exhibited intense staining for the MAC, 
lesser reactivity for C3 but IgG was absent from the foot process membranes. Smaller 
granular  deposits  of immune complexes, C3,  and  the  MAC  were observed in  the 
subendothelial  region  of the  lamina  rara  interna  and  the  lamina  densa.  Immune 
complexes may activate the classical complement pathway causing diffuse injury to 
the glomerular basement membrane (GBM), allowing subepithelial accumulation of 1902  MEMBRANE  ATTACK COMPLEX IN EXPERIMENTAL NEPHRITIS 
complexes.  These  observations  implicate  the  MAC  as  a  mediator  of GBM  and 
juxtaposed  podocyte  membrane  injury,  thereby  contributing  to  disruption  of the 
glomerular filtration barrier. 
IgG and C3 were demonstrated within tubulointerstitial  regions on the surface of 
collagen  fibers  in  close  proximity  to  the  tubular  basement  membrane  (TBM)  of 
proximal convoluted tubules.  Within the TBM, C3 localization was prominent with 
diminished  reactivity for the MAC, but IgG was not detectable.  The demonstration 
of C3  and scant  MAC deposits  in the TBM  of nonimmunized  control rats  without 
evidence  of interstitial  IgG  and  C3  deposits  suggests  that  both  nonimmune  and 
immune processes play a  role in the pathogenesis of extraglomerular lesions. 
Evidence  derived  from  these  morphologic  studies  indicates  that  the  MAC  is 
associated  with  injury to the GBM,  foot process membranes  of visceral  epithelium, 
and  the  TBM.  Further  experiments  designed  to selectively  enhance  or inhibit  the 
deposition of MAC and assess consequent renal dysfunction are required to substan- 
tiate  hypotheses  concerning  the  in  vivo  membranolytic  potential  of the  MAC  in 
experimental  immune complex glomerulonephritis. 
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